1,557 results on '"Katsiki, Niki"'
Search Results
52. Lipids: a personal view of the past decade
53. Sex and Circadian Periodicity of Cardiovascular Diseases: Are Women Sufficiently Represented in Chronobiological Studies?
54. The Interplay between Metabolic Syndrome and Religious Fasting in Postmenopausal Women
55. Nutrient Intake and Risk Factors for Metabolic Syndrome in Christian Orthodox Church Religious Fasters
56. Sodium-glucose co-transporter-2 (SGLT-2) inhibitors and uric acid: More good news!
57. Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
58. Epicardial, peripancreatic and other “orthotopic” excessive fat deposition in south Asians and Europeans: Are differences clinically relevant?
59. The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement
60. Achieving low-density lipoprotein cholesterol targets as assessed by different methods in patients with familial hypercholesterolemia: an analysis from the HELLAS-FH registry
61. Arterial stiffness correlates with progressive nailfold capillary microscopic changes in systemic sclerosis: results from a cross-sectional study
62. Prehypertension, the Risk of Hypertension and Events
63. Drug Evaluation: The Combination of Fenofibrate and Simvastatin for the Treatment of Dyslipidemia: When and for Whom?
64. NAFLD and Statins
65. Leptin, cardiovascular diseases and type 2 diabetes mellitus
66. Effect of Ezetimibe Monotherapy on Plasma Lipoprotein(a) Concentrations in Patients with Primary Hypercholesterolemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
67. Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)
68. Higher Plasma Levels of Valerate Produced by Gut Microbiota May Have a Beneficial Impact on Renal Function
69. Adherence to a Mediterranean lifestyle improves metabolic status in coronary heart disease patients: A prospective analysis from the CORDIOPREV study
70. Non-alcoholic fatty liver disease and dyslipidemia: An update
71. High-intensity statin therapy and regression of coronary atherosclerosis in patients with diabetes mellitus
72. The role of asymmetric dimethylarginine in endothelial dysfunction and abnormal nitric oxide metabolism in systemic sclerosis: results from a pilot study
73. Effect of the Mediterranean diet and probiotic supplementation in the management of mild cognitive impairment: Rationale, methods, and baseline characteristics
74. Contemporary choice of glucose lowering agents in heart failure patients with type 2 diabetes
75. The effect of bergamot on dyslipidemia
76. The effects of antiepileptic drugs on vascular risk factors: A narrative review
77. Pericoronary Adipose Tissue in Atherosclerosis: Current and Future Perspectives
78. Trend of perceived quality of life and functional capacity in outpatients with chronic heart failure and in treatment with sacubitril/valsartan: a real-life experience
79. Effect of Serum Lipid Profile on the Risk of Breast Cancer: Systematic Review and Meta-Analysis of 1,628,871 Women
80. Effects of renin-angiotensin-aldosterone system inhibitors and beta-blockers on markers of arterial stiffness
81. Statin loading in cardiovascular surgery: never too early to treat
82. Psoriasis and Cardiovascular Disease: Two Sides of the Same Coin?
83. Metabolic syndrome: joint diagnostic criteria and links with comorbidities
84. Curcuminoids Lower Plasma Leptin Concentrations: A Meta‐analysis
85. Adiposity mediates the association between whole grain consumption, glucose homeostasis and insulin resistance: findings from the US NHANES
86. Debate: Pros and cons of being a vegetarian - Pros
87. Effect of periodic religious fasting on body composition and nutrient intake in menopausal women
88. Vascular Dysfunction of COVID-19 Is Partially Reverted in the Long-Term
89. Comparison of Recent Practice Guidelines for the Management of Patients With Asymptomatic Carotid Stenosis
90. Carotid ultrasound and coronary calcium for the prediction of incident cardiac disease in asymptomatic individuals: A further step towards precision medicine especially in women?
91. Clinical benefit of statin treatment on patients with non-alcoholic fatty liver disease or steatohepatitis
92. Optimal management of asymptomatic carotid stenosis in 2021: the jury is still out. An international, multispecialty, expert review and position statement
93. 11beta-Hydroxysteroid dehydrogenase type 1 inhibitors: novel agents for the treatment of metabolic syndrome and obesity-related disorders?
94. Chrononutrition in Cardiometabolic Health
95. Optimal Management of Asymptomatic Carotid Stenosis in 2021: The Jury is Still Out. An International, Multispecialty, Expert Review and Position Statement
96. Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel
97. Adiponectin, lipids and atherosclerosis
98. Risk Scores After Acute Coronary Syndrome
99. The Heart Outcomes Prevention Evaluation (HOPE)-3 trial: where do we stand?
100. Volanesorsen: A New Era in the Treatment of Severe Hypertriglyceridemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.